OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies
Brenda Fernanda Moreira Castro, Jason C. Steel, Christopher J. Layton
BioDrugs (2023) Vol. 38, Iss. 1, pp. 73-93
Open Access | Times Cited: 7
Brenda Fernanda Moreira Castro, Jason C. Steel, Christopher J. Layton
BioDrugs (2023) Vol. 38, Iss. 1, pp. 73-93
Open Access | Times Cited: 7
Showing 7 citing articles:
Diabetic Retinopathy: New Treatment Approaches Targeting Redox and Immune Mechanisms
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 14
Qi Tang, Francesco Buonfiglio, Elsa Wilma Böhm, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 594-594
Open Access | Times Cited: 14
Therapeutic potential of AAV2-shmTOR gene therapy in reducing retinal inflammation and preserving endothelial Integrity in age-related macular degeneration
Jin Kim, Seo Yun Moon, Hyunseung Kang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Jin Kim, Seo Yun Moon, Hyunseung Kang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
AAV-mediated gene therapies for glaucoma and uveitis: are we there yet?
Brenda Fernanda Moreira Castro, Jason C. Steel, Christopher J. Layton
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 3
Brenda Fernanda Moreira Castro, Jason C. Steel, Christopher J. Layton
Expert Reviews in Molecular Medicine (2024) Vol. 26
Open Access | Times Cited: 3
Recent Advancements and Applications of Ophthalmic Gene Therapy Strategies: A Breakthrough in Ocular Therapeutics
Rashmi Maurya, Akash Vikal, Raj Kumar Narang, et al.
Experimental Eye Research (2024) Vol. 245, pp. 109983-109983
Closed Access | Times Cited: 2
Rashmi Maurya, Akash Vikal, Raj Kumar Narang, et al.
Experimental Eye Research (2024) Vol. 245, pp. 109983-109983
Closed Access | Times Cited: 2
Ocular Gene Therapy: An Overview of Viral Vectors, Immune Responses, and Future Directions
Lamprini Banou, Soshian Sarrafpour, Christopher C. Teng, et al.
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 4, pp. 491-503
Open Access | Times Cited: 2
Lamprini Banou, Soshian Sarrafpour, Christopher C. Teng, et al.
The Yale Journal of Biology and Medicine (2024) Vol. 97, Iss. 4, pp. 491-503
Open Access | Times Cited: 2
Preclinical development of a dual targeting bicistronic gene therapy approach for the treatment of wet age-related macular degeneration
Lawrence C. S. Tam, Josephine Joel, Dimitris Stampoulis, et al.
Research Square (Research Square) (2024)
Closed Access
Lawrence C. S. Tam, Josephine Joel, Dimitris Stampoulis, et al.
Research Square (Research Square) (2024)
Closed Access
Suppression of matrigel-induced choroidal neovascularization by AAV delivery of a novel anti-Scg3 antibody
Chengchi Huang, Avinash Kaur, Liyang Ji, et al.
Gene Therapy (2024)
Closed Access
Chengchi Huang, Avinash Kaur, Liyang Ji, et al.
Gene Therapy (2024)
Closed Access
